Palatin Technologies
PTN
#9897
Rank
C$51.7 M
Marketcap
C$30.37
Share price
-3.61%
Change (1 day)
2,139.23%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -C$6.94 Million

According to Palatin Technologies's latest financial reports the company's current earnings are C$8.84 Million. In 2024 the company made an earning of -C$36.9 Million, an increase over its 2023 earnings that were of -C$44.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$6.94 Million-81.21%
2024 -C$36.9 Million-16.9%
2023 -C$44.41 Million5.99%
2022 -C$41.9 Million-13.7%
2021 -C$48.55 Million33.25%
2020 -C$36.44 Million-172.11%
2019 C$50.52 M2352.33%
2018 C$2.06 M-94.13%
2017 C$35.1 M-154.92%
2016 -C$63.92 Million3.67%
2015 -C$61.66 Million878%
2014 -C$6.31 Million-72.64%
2013 -C$23.05 Million-33.11%
2012 -C$34.45 Million77.71%
2011 -C$19.39 Million
2003 -C$32.83 Million29.93%
2002 -C$25.27 Million36.18%
2001 -C$18.56 Million
1999 -C$15.4 Million6.04%
1998 -C$14.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.37 B-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$17.93 B-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$0.79 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-C$16.45 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$91.49 M-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$69.24 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-C$40.39 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-C$76.1 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA